{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:12:07Z","timestamp":1789099927386,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16K08946"],"award-info":[{"award-number":["16K08946"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26860375"],"award-info":[{"award-number":["26860375"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K09139"],"award-info":[{"award-number":["17K09139"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, metabolic syndrome, and type II diabetes mellitus. Recently, circulating microRNAs (miRNAs) have been proposed as useful disease biomarkers. We examined whether circulating miRNAs, such as miR-20a, miR-27a, and miR-126, were useful biomarkers for NAFLD. We conducted a cross-sectional analysis of 527 subjects aged 39 years or older who had undergone a health examination in the Yakumo Study. Of the residents, 92 were diagnosed with NAFLD using a registered medical sonographer. Serum miR-20a, miR-27a and miR-126 levels were measured by quantitative real-time PCR. We then calculated the odds ratios for serum miRNA level changes according to the severity of NAFLD using normal liver status as the reference group. Serum levels of miR-20a and 27a, but not miR-126, were significantly lower in NAFLD subjects than normal subjects. Serum miR-20a and miR-27a levels were significantly lower in both male and female severe NAFLD subjects. Logistic regression analysis showed a significant relationship between low circulating miR-20a and 27a levels and severe NAFLD. Down-regulated circulating miR-20a and 27a levels were significantly associated with severe NAFLD in the general population. Circulating miR-20a and miR-27a may be useful biomarkers for severe NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-019-55076-z","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:44:58Z","timestamp":1576068298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population"],"prefix":"10.1038","volume":"9","author":[{"given":"Yoshitaka","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirai","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Munetsuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Ichino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Osakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Teradaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiji","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hamajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"55076_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto, E., Taniai, M. & Tokushige, K. Characteristics and diagnosis of NAFLD\/NASH. J Gastroenterol Hepatol 28, 64\u201370 (2013).","journal-title":"J Gastroenterol Hepatol"},{"key":"55076_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos, S. A., Kountouras, J. & Mantzoros, C. S. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 92, 82\u201397 (2019).","journal-title":"Metabolism"},{"key":"55076_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","volume":"418","author":"M Asrih","year":"2015","unstructured":"Asrih, M. & Jornayvaz, F. R. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol Cell Endocrinol 418, 55\u201365 (2015).","journal-title":"Mol Cell Endocrinol"},{"key":"55076_CR4","doi-asserted-by":"publisher","first-page":"450639","DOI":"10.1155\/2013\/450639","volume":"2013","author":"AN Mavrogiannaki","year":"2013","unstructured":"Mavrogiannaki, A. N. & Migdalis, I. N. Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol 2013, 450639 (2013).","journal-title":"Int J Endocrinol"},{"key":"55076_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam, M., Valenti, L. & Romeo, S. Genetics and epigenetics of NAFLD and NASH: Clinical impact. J Hepatol 68, 268\u2013279 (2018).","journal-title":"J Hepatol"},{"key":"55076_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.lfs.2016.02.020","volume":"149","author":"M Yamazaki","year":"2016","unstructured":"Yamazaki, M. et al. Fructose consumption induces hypomethylation of hepatic mitochondrial DNA in rats. Life Sci 149, 146\u2013152 (2016).","journal-title":"Life Sci"},{"key":"55076_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","volume":"424","author":"H Yamada","year":"2013","unstructured":"Yamada, H. et al. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 424, 99\u2013103 (2013).","journal-title":"Clin Chim Acta"},{"key":"55076_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2015.10.134","volume":"468","author":"K Ohashi","year":"2015","unstructured":"Ohashi, K. et al. High fructose consumption induces DNA methylation at PPARalpha and CPT1A promoter regions in the rat liver. Biochem Biophys Res Commun 468, 185\u2013189 (2015).","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"55076_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/ijms19030911","volume":"19","author":"Jos\u00e9 Del Campo","year":"2018","unstructured":"Del Campo, J. A., Gallego-Duran, R., Gallego, P. & Grande, L. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). Int J Mol Sci 19, https:\/\/doi.org\/10.3390\/ijms19030911 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"55076_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"55076_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"MA Cortez","year":"2011","unstructured":"Cortez, M. A. et al. MicroRNAs in body fluids\u2013the mix of hormones and biomarkers. Nat Rev Clin Oncol 8, 467\u2013477 (2011).","journal-title":"Nat Rev Clin Oncol"},{"key":"55076_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/met.2017.0101","volume":"16","author":"E Ma","year":"2018","unstructured":"Ma, E., Fu, Y. & Garvey, W. T. Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans. Metab Syndr Relat Disord 16, 82\u201389 (2018).","journal-title":"Metab Syndr Relat Disord"},{"key":"55076_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","volume":"120","author":"J Viereck","year":"2017","unstructured":"Viereck, J. & Thum, T. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury. Circ Res 120, 381\u2013399 (2017).","journal-title":"Circ Res"},{"key":"55076_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0004563217735124","volume":"55","author":"E Munetsuna","year":"2018","unstructured":"Munetsuna, E. et al. Association of subcutaneous and visceral fat with circulating microRNAs in a middle-aged Japanese population. Ann Clin Biochem 55, 437\u2013445 (2018).","journal-title":"Ann Clin Biochem"},{"key":"55076_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.clinre.2016.11.001","volume":"41","author":"K Pant","year":"2017","unstructured":"Pant, K. & Venugopal, S. K. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clin Res Hepatol Gastroenterol 41, 370\u2013377 (2017).","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"55076_CR16","doi-asserted-by":"publisher","first-page":"17644","DOI":"10.3390\/ijms151017644","volume":"15","author":"LS Enache","year":"2014","unstructured":"Enache, L. S. et al. Circulating RNA molecules as biomarkers in liver disease. Int J Mol Sci 15, 17644\u201317666 (2014).","journal-title":"Int J Mol Sci"},{"key":"55076_CR17","first-page":"2669","volume":"18","author":"J Nie","year":"2018","unstructured":"Nie, J., Li, C. P., Li, J. H., Chen, X. & Zhong, X. Analysis of nonalcoholic fatty liver disease microRNA expression spectra in rat liver tissues. Mol Med Rep 18, 2669\u20132680 (2018).","journal-title":"Mol Med Rep"},{"key":"55076_CR18","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1159\/000447917","volume":"39","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity. Cell Physiol Biochem 39, 2239\u20132248 (2016).","journal-title":"Cell Physiol Biochem"},{"key":"55076_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2015.05.002","volume":"446","author":"H Yamada","year":"2015","unstructured":"Yamada, H. et al. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Clin Chim Acta 446, 267\u2013271 (2015).","journal-title":"Clin Chim Acta"},{"key":"55076_CR20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1089\/dna.2014.2760","volume":"34","author":"X Feng","year":"2015","unstructured":"Feng, X. et al. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-kappaB pathway. DNA Cell Biol 34, 470\u2013480 (2015).","journal-title":"DNA Cell Biol"},{"key":"55076_CR21","first-page":"3067","volume":"9","author":"GS Chen","year":"2016","unstructured":"Chen, G. S. et al. Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells. Onco Targets Ther 9, 3067\u20133076 (2016).","journal-title":"Onco Targets Ther"},{"key":"55076_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1039\/C6MB00596A","volume":"13","author":"YO Nunez Lopez","year":"2016","unstructured":"Nunez Lopez, Y. O., Garufi, G. & Seyhan, A. A. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol Biosyst 13, 106\u2013121 (2016).","journal-title":"Mol Biosyst"},{"key":"55076_CR23","doi-asserted-by":"crossref","unstructured":"Villard, A., Marchand, L., Thivolet, C. & Rome, S. Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis. J Mol Biomark Diagn 6 (2015).","DOI":"10.4172\/2155-9929.1000251"},{"key":"55076_CR24","doi-asserted-by":"publisher","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","volume":"97","author":"DS Karolina","year":"2012","unstructured":"Karolina, D. S. et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97, E2271\u20132276 (2012).","journal-title":"J Clin Endocrinol Metab"},{"key":"55076_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2015.05.017","volume":"463","author":"T Zhang","year":"2015","unstructured":"Zhang, T. et al. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun 463, 60\u201363 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"55076_CR26","doi-asserted-by":"publisher","first-page":"10567","DOI":"10.3390\/ijms150610567","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci 15, 10567\u201310577 (2014).","journal-title":"Int J Mol Sci"},{"key":"55076_CR27","first-page":"761617","volume":"2013","author":"T Zhang","year":"2013","unstructured":"Zhang, T. et al. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int 2013, 761617 (2013).","journal-title":"Biomed Res Int"},{"key":"55076_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/2211536607666180402120806","volume":"7","author":"JG Hijmans","year":"2018","unstructured":"Hijmans, J. G. et al. Influence of Overweight and Obesity on Circulating Inflammation-Related microRNA. Microrna 7, 148\u2013154 (2018).","journal-title":"Microrna"},{"key":"55076_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1423-0127-20-72","volume":"20","author":"YT Wang","year":"2013","unstructured":"Wang, Y. T., Tsai, P. C., Liao, Y. C., Hsu, C. Y. & Juo, S. H. Circulating microRNAs have a sex-specific association with metabolic syndrome. J Biomed Sci 20, 72 (2013).","journal-title":"J Biomed Sci"},{"key":"55076_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.mad.2012.09.004","volume":"133","author":"F Olivieri","year":"2012","unstructured":"Olivieri, F. et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 133, 675\u2013685 (2012).","journal-title":"Mech Ageing Dev"},{"key":"55076_CR31","doi-asserted-by":"publisher","first-page":"e13735","DOI":"10.1371\/journal.pone.0013735","volume":"5","author":"H Zhao","year":"2010","unstructured":"Zhao, H. et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5, e13735 (2010).","journal-title":"PLoS One"},{"key":"55076_CR32","doi-asserted-by":"publisher","first-page":"e105192","DOI":"10.1371\/journal.pone.0105192","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan, Y., Ge, G., Pan, T., Wen, D. & Gan, J. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS One 9, e105192 (2014).","journal-title":"PLoS One"},{"key":"55076_CR33","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1089\/thy.2016.0062","volume":"26","author":"I Hiratsuka","year":"2016","unstructured":"Hiratsuka, I., Yamada, H., Munetsuna, E., Hashimoto, S. & Itoh, M. Circulating MicroRNAs in Graves\u2019 Disease in Relation to Clinical Activity. Thyroid 26, 1431\u20131440 (2016).","journal-title":"Thyroid"},{"key":"55076_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/cen.12432","volume":"81","author":"H Yamada","year":"2014","unstructured":"Yamada, H., Itoh, M., Hiratsuka, I. & Hashimoto, S. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol (Oxf) 81, 276\u2013281 (2014).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"55076_CR35","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","volume":"69","author":"CH Liu","year":"2018","unstructured":"Liu, C. H. et al. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol 69, 1335\u20131348 (2018).","journal-title":"J Hepatol"},{"key":"55076_CR36","doi-asserted-by":"publisher","first-page":"e0153497","DOI":"10.1371\/journal.pone.0153497","volume":"11","author":"NC Salvoza","year":"2016","unstructured":"Salvoza, N. C., Klinzing, D. C., Gopez-Cervantes, J. & Baclig, M. O. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. PLoS One 11, e0153497 (2016).","journal-title":"PLoS One"},{"key":"55076_CR37","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1021\/acs.analchem.9b00821","volume":"91","author":"Y Deng","year":"2019","unstructured":"Deng, Y. et al. Ratio-Based Method To Identify True Biomarkers by Normalizing Circulating ncRNA Sequencing and Quantitative PCR Data. Anal Chem 91, 6746\u20136753 (2019).","journal-title":"Anal Chem"},{"key":"55076_CR38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325, https:\/\/doi.org\/10.1002\/hep.21178 (2006).","journal-title":"Hepatology"},{"key":"55076_CR39","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22569","volume":"48","author":"O Cheung","year":"2008","unstructured":"Cheung, O. et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48, 1810\u20131820 (2008).","journal-title":"Hepatology"},{"key":"55076_CR40","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J Hepatol 62, S47\u201364 (2015).","journal-title":"J Hepatol"},{"key":"55076_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/jcmm.12835","volume":"20","author":"W Fang","year":"2016","unstructured":"Fang, W. et al. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression. J Cell Mol Med 20, 1467\u20131480 (2016).","journal-title":"J Cell Mol Med"},{"key":"55076_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2018.07.029","volume":"208","author":"D Ye","year":"2018","unstructured":"Ye, D. et al. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients. Life Sci 208, 201\u2013207 (2018).","journal-title":"Life Sci"},{"key":"55076_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","volume":"583","author":"J Ji","year":"2009","unstructured":"Ji, J. et al. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583, 759\u2013766 (2009).","journal-title":"FEBS Lett"},{"key":"55076_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15141-x","volume":"7","author":"M Zhang","year":"2017","unstructured":"Zhang, M., Sun, W., Zhou, M. & Tang, Y. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1. Sci Rep 7, 14493 (2017).","journal-title":"Sci Rep"},{"key":"55076_CR45","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/j.1742-4658.2009.06967.x","volume":"276","author":"Q Lin","year":"2009","unstructured":"Lin, Q., Gao, Z., Alarcon, R. M., Ye, J. & Yun, Z. A role of miR-27 in the regulation of adipogenesis. FEBS J 276, 2348\u20132358 (2009).","journal-title":"FEBS J"},{"issue":"3","key":"55076_CR46","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"Ruben Hernaez","year":"2011","unstructured":"Hernaez, R. et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54 (2011).","journal-title":"Hepatology"},{"key":"55076_CR47","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.2214\/AJR.07.2123","volume":"189","author":"S Strauss","year":"2007","unstructured":"Strauss, S., Gavish, E., Gottlieb, P. & Katsnelson, L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189, W320\u2013323 (2007).","journal-title":"AJR Am J Roentgenol"},{"key":"55076_CR48","doi-asserted-by":"publisher","unstructured":"Fujii, R. et al. Associations of circulating microRNAs (miR-17, miR-21, and miR-150) and chronic kidney disease in a Japanese population. J Epidemiol, https:\/\/doi.org\/10.2188\/jea.JE20180233 (2019).","DOI":"10.2188\/jea.JE20180233"},{"key":"55076_CR49","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7, 1104\u20131112 (2009).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"55076_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.archger.2019.01.007","volume":"82","author":"M Kondo","year":"2019","unstructured":"Kondo, M. et al. Associations of serum microRNA-20a, -27a, and -103a with cognitive function in a Japanese population: The Yakumo study. Arch Gerontol Geriatr 82, 155\u2013160 (2019).","journal-title":"Arch Gerontol Geriatr"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55076-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55076-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55076-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:20:15Z","timestamp":1671297615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55076-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55076"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55076-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18856"}}